#United States #New York #Class Action #Gross Law Firm #Biohaven Ltd

Biohaven Ltd. Class Action Lawsuit Alert

On July 28, 2025, The Gross Law Firm announced an important update for shareholders of Biohaven Ltd. (NYSE: BHVN). Those who acquired shares during the specified class period are encouraged to engage with the firm regarding potential lead plaintiff roles. It is important to note that becoming a lead plaintiff is not necessary to participate in any potential recovery.

Class Period and Allegations

The class period in question spans from March 24, 2023, to May 14, 2025. The allegations in the complaint suggest that during this timeframe, the defendants made numerous materially false or misleading statements. Additionally, it is alleged that there was a failure to disclose significant information, leading investors to have an inflated perception of both the company’s product candidate, troriluzole, and its proposed efficacy in treating various health conditions, including SCA and bipolar disorder.

Key Points from the Allegations:

1. Misleading Statements: The claims allege that the regulatory prospects for troriluzole were overstated.
2. Efficacy Concerns: Concerns regarding BHV-7000's effectiveness were allegedly overstated as well.
3. Impact on Business: It is believed that once these issues were publicly revealed, the company's financial stability and market value would be adversely affected.
4. Continuing Deception: Essentially, defendants’ misleading communication persisted throughout the relevant times, impairing the trust of investors.

Next Steps for Shareholders

To be eligible for participation in this class action, shareholders are advised to register their information promptly. The deadline for submitting a request to be appointed as a lead plaintiff is September 12, 2025. Registration is complete with no associated costs or obligations.

Additionally, once registered, investors will be provided with portfolio monitoring software that offers consistent updates about the case’s progress.

Why Choose The Gross Law Firm?

The Gross Law Firm is a reputable class action law firm dedicated to safeguarding the rights of investors who may have been misled or suffered due to fraudulent practices. Their commitment extends to holding companies accountable for transparent operations and ethical conduct. They strive for recovery on behalf of those whose investments declined as a direct result of dishonest or deceptive business practices.

Contact Information

Investors seeking to engage with The Gross Law Firm can reach out directly:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

In summary, current and prospective shareholders of Biohaven Ltd. should not delay in taking action regarding this class action lawsuit. Engaging with The Gross Law Firm provides an opportunity to navigate this critical situation effectively and may lead to a recovery of lost investments due to the alleged fraudulent activities.

Stay tuned for further updates as this case develops, and ensure your participation by registering before the upcoming deadline.